Synthesizing a Derivative of the Anti-Cancer Drug DW2282
Dr. Anthony Molinero, Advisor
The goal of my project is to successfully synthesize derivatives of an anti-cancer drug in the class Diarylsulfonylurea called DW2282. This drug has shown great promise for killing cancer cells in the past, having an activity similar to that of Taxol's © (currently being used today).
By synthesizing DW2282 I hope to modify its structure in order to create a derivative with greater activity, thereby making a cancer drug that is easier and cheaper to make than Taxol.